Atlas Trials

Pirfenidone for Restrictive Chronic Lung Allograft Dysfunction

Clinical trial NCT03359863 · COMPLETED

Trial details

NCT number
NCT03359863
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Restrictive Chronic Lung Allograft DysfunctionLung Transplant Rejection
Start date
2018-03-07
Primary completion
2021-10-28
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.